A research team led by Kuang Guangli and Jiang Donghui at the High Magnetic Field Laboratory of the Hefei Institutes of Physical Science of the Chinese Academy of Sciences (CHMFL), has developed a ...
Dec. 15, 2025 — For decades, when tests suggested that a man might have prostate cancer, the next step was usually a biopsy. The procedure, where a doctor uses a thin needle to collect prostate ...
MARKHAM, Ontario--(BUSINESS WIRE)--Exact Imaging today announced results from its OPTIMUM clinical trial demonstrating the non-inferiority of its ExactVu™ micro-ultrasound platform to MRI ...
Certification opens the European market for the first FDA-cleared AI platform for prostate MRI interpretation. OMAHA, Neb., Oct. 27, 2025 /PRNewswire/ -- Bot Image, Inc., a leader in AI-powered ...
Clinically significant cancer was detected in 29.2 versus 29.6 percent of men with biparametric and multiparametric MRI. HealthDay News — Biparametric magnetic resonance imaging (MRI), which omits the ...
Biparametric MRI, omitting gadolinium contrast, is noninferior to multiparametric MRI for detecting significant prostate cancer, offering a faster, cheaper alternative. The PRIME trial involved 490 ...
Biparametric MRI, which omits the dynamic contrast enhancement sequence, can detect clinically significant prostate cancer as well as multiparametric MRI. Biparametric MRI performs as well as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results